•  
  •  
  •  
  •  

2025-11-29 05:00:51

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Veefin Wins Supply Chain Finance Mandate from Bank of the Philippine Islands for Philippines Deployment
  • Arvind SmartSpaces adds a new premium residential high-rise project in Ahmedabad with a top-line potential of ~Rs. 400 crore
  • MAHAGENCO and NTPC consortium's resolution plan for Sinnar Thermal Power Ltd approved by NCLT
  • Patel Engineering Ltd fixes Dec 4, 2025 as record date for 7:40 rights issue
  • Ramky Infrastructure Ltd wins award ET INFRA LEADERSHIP Awards 2025

Keywords Selected:  JagsonpalPharmaceuticals

Stock Report

  • Jagsonpal Pharmaceuticals Ltd Q2FY26 PAT up at Rs. 12.57 crores
  • Jagsonpal Pharmaceuticals Ltd Q1 FY2025-26 net profit climbs to Rs. 10.79 crores
  • Jagsonpal Pharmaceuticals Limited recommends dividend of Rs. 2.5
  • Jagsonpal Pharmaceuticals Ltd Q4 FY2025 PAT slides QoQ to Rs. 6.58 crores
  • Jagsonpal Pharmaceuticals Ltd Q3 FY2024-25 net profit jumps to Rs. 31.99 crores
  • Jagsonpal Pharmaceuticals Limited fixes Jan 8, 2025 as record date for stock split
  • Jagsonpal Pharmaceuticals Ltd Q2 FY2024-25 net profit rises to Rs. 11.45 crores
  • Jagsonpal Pharmaceuticals launches QueeZy-ERĀ®
  • Jagsonpal Pharmaceuticals Ltd posts Rs. 7.47 crore PAT in Q2 FY24
  • Jagsonpal Pharmaceuticals Ltd Q1 FY2024 PAT up at Rs. 7.47 crore
  • Jagsonpal Pharmaceuticals Ltd recommends dividend of Rs. 5
  • Jagsonpal Pharmaceuticals Ltd Q4 FY2023 PAT slips QoQ to Rs. 5.60 crores
  • Jagsonpal Pharmaceuticals Ltd Q3 FY2023 PAT drops QoQ to Rs. 7.78 crores
  • Jagsonpal Pharmaceuticals Ltd reports rise in Q2FY23 net profit to Rs. 10.41 crores
  • Jagsonpal Pharmaceuticals appoints Mr. Manish Gupta as the MD
  • Infinity Holdings Group to acquire majority stake in Jagsonpal Pharmaceuticals Ltd
  • Jagsonpal Pharmaceuticals Q3FY22 PAT slips to Rs. 5.40 crores
  • Jagsonpal Pharmaceuticals Ltd Board declares Interim Dividend of Rs. 4
  • Jagsonpal Pharmaceuticals Ltd Q2FY22 PAT at Rs. 7.30 crore

Latest Post

  • Veefin Wins Supply Chain Finance Mandate from Bank of the Philippine Islands for Philippines Deployment
  • Arvind SmartSpaces adds a new premium residential high-rise project in Ahmedabad with a top-line potential of ~Rs. 400 crore
  • MAHAGENCO and NTPC consortium's resolution plan for Sinnar Thermal Power Ltd approved by NCLT
  • Patel Engineering Ltd fixes Dec 4, 2025 as record date for 7:40 rights issue
  • Ramky Infrastructure Ltd wins award ET INFRA LEADERSHIP Awards 2025


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024